Callan JMB Inc. (CJMB) AI Stock Analysis
CJMB AI stock analysis summary
AI ResearchCallan JMB Inc. (CJMB) provides thermal management logistics solutions for the life sciences sector. Its revenue decreased from $22.8M in FY2022 to $5.7M in FY2025, with a trailing twelve month net profit margin of -192.0%. As of June 30, 2026, the company held $860,273 in cash and short-term investments against a market capitalization of $14.6M.
- Market cap
- $14.6M
- Revenue (TTM)
- $5.1M
- P/E
- —
- 1Y return
- -44.7% S&P 500 16.8%
- Avg. target
- —
Bull case
- The stock has generated a year-to-date return of 98.2% and traded 38.8% above its 200-day average as of October 16, 2026.
- Company insiders own 56.4% of total equity, showing substantial ownership alignment.
- Short-term obligations remain covered with a current ratio of 1.30 as of June 30, 2026.
Bear case
- Revenue fell at a 3-year CAGR of -36.9% between FY2022 and FY2025, dropping from $22.8M to $5.7M.
- Net income dropped from $6.2M in FY2022 to -$8.0M in FY2025, accompanied by free cash flow of -$5.2M.
- Total debt of $2.1M exceeds cash and short-term investments of $860,273 as of June 30, 2026, resulting in a debt-to-equity ratio of 3.14.
What Callan JMB does
Callan JMB Inc., through its subsidiary Coldchain Technology Services, LLC, provides thermal management logistics solutions to the life sciences industry in the United States. It offers logistics solutions and services utilized for frozen shipping, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, and biopharmaceuticals. The company also provides emergency preparedness services such as managing building sites and medical stockpiles, specialty temperature-regulating packaging, technical services, and advanced monitoring sentry technology. In addition, the company engages in oil and gas development and maintains a strategic partnership with Alabama State University.
Growth and profitability
Annual revenue contracted from $22.8M in FY2022 to $13.2M in FY2023, $6.6M in FY2024, and $5.7M in FY2025, resulting in a 3-year revenue CAGR of -36.9%. Over the same timeframe, gross margin decreased from 41.5% to 36.8%, and operating margin fell from 27.7% to -113.4%. Net income dropped from $6.2M in FY2022 to -$8.0M in FY2025, with net margin reaching -139.2% and EPS at -$1.77. Over the trailing twelve months, revenue was $5.1M with an operating margin of -97.8% and EPS of -$1.97. In the latest quarter ended June 30, 2026, quarterly revenue growth declined 17.4% year-over-year.
Balance sheet and cash flow
As of June 30, 2026, Callan JMB Inc. held $860,273 in cash and short-term investments and total debt of $2.1M, resulting in net debt of $1.3M. Total assets were $4.5M and shareholders' equity was $681,863, yielding a debt-to-equity ratio of 3.14 and a current ratio of 1.30. In FY2025, operating cash flow was -$4.5M, free cash flow was -$5.2M, and capital expenditures were $616,896.
Valuation and performance
At the last close price of $2.20 on October 16, 2026, Callan JMB Inc. had a market capitalization of $14.6M and an enterprise value of $15.4M. It traded at a price-to-sales multiple of 2.9x and an EV to revenue ratio of 3.0x, above the median of its US-listed Industrials peers price-to-sales ratio of 1.5x. Its price-to-book ratio stood at 20.7x. Over the past year, the stock fell 44.7%, trailing the S&P 500 (SPY) return of 16.8%, though its year-to-date return was 98.2%.
What analysts expect
Callan JMB Inc. delivered 0 EPS beats over the last 4 quarters. The next earnings date is scheduled for November 13, 2026. Insider ownership stands at 56.4%, institutional ownership is 10.8%, and short interest accounts for 4.2% of the float.
Key risks and what to watch
- Quarterly revenue growth fell 17.4% year-over-year in the latest quarter ended June 30, 2026.
- Cash reserves stood at $860,273 as of June 30, 2026, following an operating cash flow outflow of -$4.5M in FY2025.
- The company generated a trailing twelve month net profit margin of -192.0% and return on equity of -300.3%.
- Over the trailing 1-year period, the stock declined 44.7% compared to a 16.8% gain for the S&P 500 (SPY).
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this CJMB AI stock analysis
This page is an AI-written research summary of Callan JMB Inc. (CJMB). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: CJMB income statement, CJMB balance sheet, CJMB key metrics, CJMB chart. See the CJMB stock overview for the latest quote and news.
CJMB AI stock analysis FAQ
When does Callan JMB Inc. report earnings next?
Callan JMB Inc.'s next scheduled earnings date is November 13, 2026.
What is Callan JMB Inc.'s price-to-sales ratio relative to its sector peers?
Callan JMB Inc. trades at a price-to-sales multiple of 2.9x, compared to 1.5x for the median of its US-listed Industrials peers.
How much cash and debt does Callan JMB Inc. have?
As of June 30, 2026, the company had $860,273 in cash and short-term investments, $2.1M in total debt, and net debt of $1.3M.
What is the level of insider ownership in CJMB?
Insiders hold 56.4% of the company's shares as of October 16, 2026.